Your Flagship Event Driving ADC Innovation, Insights & Connections

Pfizer pens $10B, 12-drug deal with Innovent in broad bet on Chinese cancer med innovation
Iza-Bren Is Approved in China for Recurrent/Metastatic Nasopharyngeal Carcinoma
Novartis to acquire Myricx Bio for up to $1.5B, adding cancer-fighting ADC payload platform
Daiichi, AstraZeneca’s Enhertu breaks into early breast cancer with dual FDA approvals
Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC, fueling TROP2 ADC market war
J&J makes $1B upfront bet on emerging DAC space by netting Firefly Bio

Modeling ADC Payload Biology Using Simulated Cells

Modeling ADC Payload Biology Using Simulated Cells

12:30 pm - Wednesday 14th October 2026

Presenting a cell signaling network-based computational model of cytotoxic payloads
Showcasing predicted response from test samples across cancer subtypes, including SLFN11 and SN38-Prexasertib
Demonstrating the value of cell simulations to predict drug perturbations and reveal mechanistic insights

Speakers:

Jerzy Woznicki

Jerzy Woznicki

Dr

Turbine.AI